Inside Stayble: December 2020

22 December 2020

In the December 2020 edition, CEO Andreas Gerward, explains the upcoming rights issue more in-depth and reflects over 2020 and the upcoming 2021.

Inside Stayble is a new communication channel aiming to provide shareholders with monthly updates about Stayble Therapeutics and its clinical development program for STA363 in chronic low back pain.

Stayble Therapeutics is listed on Nasdaq First North in Sweden (STABL).